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Background: People living with HIV are living longer and are more likely to die from chronic 
conditions than other causes, many of which are associated with cigarette smoking. People living 
with HIV also have a higher prevalence of cigarette smoking. Smoking cessation strategies are 
therefore an important area of research to focus on, but female smokers with HIV are an under-
studied population. 
Objectives: To compare the prevalence and effectiveness of smoking cessation methods and 
determine characteristics associated with sustained (6-12-month) smoking cessation among 
women with and at risk for HIV. 
Methods: We used data from the Women’s Interagency HIV Study (WIHS), the largest ongoing 
prospective cohort study of HIV among women in the United States, to study smoking cessation 
methods among female smokers with HIV. 
Analysis: We compared incidence of sustained smoking cessation among women who tried to 
quit smoking in the WIHS, and used a generalized linear model using Poisson regression to 
determine characteristics associated with sustained smoking cessation. 
Results: The proportion of women achieving 6-12 month sustained smoking cessation was 
highest among those using  self-help interventions (36%), other pharmacological aids such as 
Chantix, Wellbutrin, and Bupropion (35%), quitting “on her own” (35%), and quitting “cold 
turkey” (32%). The most prevalent method cited was nicotine replacement therapy. 
Characteristics associated with achieving 6-12-month sustained smoking cessation included 
fewer number of cigarettes smoked prior to quitting, fewer years smoked prior to quitting, having 
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her own place of residence, and higher self-rated health, regardless of which smoking cessation 
method used. 
Conclusions: Smoking history, residence, and higher self-rated health are associated with 
achieving sustained smoking cessation among women in the WIHS. Self-directed smoking 
cessation therapies, like self-help interventions and quitting “cold turkey”, and nicotine 
replacement therapy are methods with the highest proportion of 6-12-month sustained smoking 
cessation among women who reported using them. 
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Despite the decrease in the prevalence of cigarette smoking in the United States over the 
last fifty years, smoking prevalence remains high among people living with HIV (Mdodo, 2015). 
Now that people diagnosed with HIV are living longer, thanks to the widespread availability and 
use of antiretroviral therapies, the causes of death for people living with HIV are now more 
likely to be chronic conditions (Deeks, 2013). Many of these conditions, such as cardiovascular 
disease, pulmonary conditions, and lung cancer, are associated with cigarette smoking. As more 
people with HIV live longer and develop more of these conditions, research is needed on the 
impact of smoking in HIV-infected populations. 
Globally, there are 1 billion smokers, 80% of whom live in low- and middle-income 
countries (WHO, 2016). These are also the countries in which the burden of the HIV epidemic is 
most intense (UNAIDS, 2016). It is estimated that 40-70% of people living with HIV in the 
United States are cigarette smokers (Mdodo, 2015), which is higher than the general US 
population’s smoking prevalence of 15.1% (CDC, 2016). People living with HIV are therefore 
an important group on which to focus smoking cessation efforts. 
The trends and predictors of cigarette smoking have been described in various sub-
populations of people living with HIV. Globally, men are more likely to be current smokers than 
women, among people living with HIV, although in the United States, men and women have 
similar prevalence of cigarette smoking (Weinberger, 2017). A survey of adults with HIV found 
that non-Hispanic white and non-Hispanic black race was independently associated with greater 
smoking prevalence (Mdodo, 2015), and Gritz et al. (2004) found that white participants were 
more likely to be current smokers than Hispanic participants. Among men who have sex with 
men in the Multicenter AIDS Cohort Study in 2012, 11.8% of men who enrolled before 2001 and 
 
 2 
36.9% of men who enrolled during or after 2001 were current smokers (Akhtar-Khaleel, 2016). 
Being black or non-Hispanic, lower education, and alcohol and marijuana use were positively 
associated with current cigarette smoking in MACS (Akhtar-Khaleel, 2016). HIV serostatus was 
not associated with cigarette smoking, but detectable viral load was (Akhtar-Khaleel, 2016). As 
of March 2016, 39% of HIV+ and 47% of HIV-uninfected women were current smokers, and 
28% of each group were former smokers (unpublished data). 
 Smoking has a serious effect on the health of people living with HIV. HIV-infected 
smokers now lose more years of their lives to cigarette smoking than to HIV infection 
(Helleberg, 2013). A study of veterans in the United States living with HIV found that the 
mortality rate for smokers was twice that of non-smokers, even after adjusting for age, CD4 
count, and viral load (Crothers, 2007). Smoking is associated with increased morbidity and 
mortality, especially related to cardiovascular disease, respiratory conditions, and cancer. 
Worldwide, smoking and tobacco use causes more than 5 million deaths per year (WHO, 2016). 
People living with HIV have a disproportionately high risk for cardiovascular disease (Barbaro, 
2003). People living with HIV also have elevated risks of respiratory-related conditions, such as 
chronic obstructive pulmonary disease and bacterial pneumonia (Crothers, 2005). In the HIV 
Epidemiologic Research Study (HERS), the most significant clinical risk factor for the 
development of bacterial pneumonia was current cigarette smoking (Kohli, 2006). Lung cancer is 
also a concern, given the clear causal association between smoking and lung cancer. Lung cancer 
is now the third most commonly diagnosed cancer among people living with HIV, behind 
Kaposi’s sarcoma and non-Hodgkins lymphoma (Kirk, 2007). The risk of developing lung 




 Smoking also has an adverse effect on HIV-related outcomes. Findings from the WIHS 
suggest that smokers are more likely than non-smokers to have poorer viral and immunologic 
responses, more frequent immunologic failure, a higher risk of developing AIDS, and a higher 
risk of pregnancy loss (Feldman, 2006, Westreich, 2017). This could be due to the relationship of 
cigarette smoking and HAART adherence. One study found that smokers were significantly 
more likely to report non-compliance with HAART regimens in the last 6 months than non-
smokers (Feldman, 2006). Another study found that cigarette smoking can decrease the response 
to HAART by 40% (Miguez-Burbano, 2005). 
Other psychiatric and social-level characteristics are associated with smoking in people 
living with HIV. Among HIV-infected individuals, those who were depressed were more likely 
to smoke (Stewart, 2011).  Heavy drinking (Gritz, 2004) and illegal drug use (Burkhalter, 2005) 
have also been found to be associated with cigarette smoking in people living with HIV. In a 
study of people living with HIV, both who inject drugs and who do not, current injectors had a 
higher smoking prevalence and greater daily cigarette consumption compared to former injectors 
(Marshall, 2011). 
Given the adverse effects of cigarette smoking among people living with HIV, smoking 
cessation is a major health goal for care of people living with HIV (PLWH). However, it is 
important to recognize that different sub-populations of smokers living with HIV have different 
cessation and recidivism rates. For example, in the WIHS, factors associated with taking a longer 
time to cessation among smokers included less education, alcohol use, having health insurance, 
>10-year smoking history, self-reported poor health rating, and having hypertension (Hessol, 
2014). Pregnancy in the last six months was associated with a shorter time to smoking cessation 
(Hessol, 2014). Hessol et al. (2014) also investigated the factors associated with time to smoking 
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relapse after cessation, and found that marijuana use and not living in one’s own place were 
associated with shorter time to recidivism. Among HIV-infected women, older age and HAART 
use were associated with longer time to recidivism (Hessol, 2014). 
Perceived barriers to smoking cessation, among both smokers and health care providers, 
are also crucial to understand. At the individual smoker level, some research has shown that 
some people living with HIV do not think they will live long enough to suffer the health 
consequences of cigarette smoking (Burkhalter, 2005). Burkhalter et al. (2005) also found that 
greater levels of emotional stress were associated with less readiness and interest in smoking 
cessation. There are also barriers among health care providers. A survey of HIV provider 
attitudes and practices found that 55% of HIV care providers said they were not confident in 
their ability to provide smoking cessation advice to their patients (Horvath, 2012). Furthermore, 
60% of these providers said that they believe that their patients know that smoking is a health 
problem, but do not want to quit (Horvath, 2012). 
Despite the prevalence of cigarette smoking in people living with HIV, and the health 
impacts resulting from smoking, little research has been done on the effectiveness of smoking 
cessation interventions. A review of the literature by Pacek and Crum (2015a) found few studies 
that had been conducted to evaluate interventions, and speculated that this lack of focus could be 
due to a few reasons: the desire of practitioners to focus on acute treatment to a life threatening 
disease, a belief that other substance use issues should be addressed first, or, a lack of specific 
interventions tailored to the HIV-infected population. Focus on smoking cessation interventions 
is important, because a significant portion of smokers in the general population attempts to quit 
each year (more than half of adult smokers in 2010 [CDC, 2011]), and cessation interventions 
can increase the success of quit attempts. One study found that smokers who seek out cessation 
 
 5 
interventions are twice as likely to be abstinent from smoking at 12 months than smokers who do 
not seek out cessation interventions (Zhu, 2000). However, cessation rates in HIV-positive 
populations are different than the general population. One study of HIV-infected and at risk 
women from the WIHS found that both groups of women have lower smoking cessation rates 
than the general population (Goldberg, 2010). 
Smoking cessation interventions can be broadly grouped into two categories: behavioral 
and counseling interventions, and pharmacological interventions, including nicotine replacement 
therapy (NRT). Counseling interventions are fairly common – one study found that 81% of 
current smokers living with HIV reported receiving medical advice to quit smoking in the past 
year (Burkhalter, 2005). Some of the behavioral and counseling interventions tested among 
people living with HIV have been shown to be effective. Huber et al. (2012), using data from the 
Swiss HIV Cohort Study, found that training physicians in a cessation counseling intervention 
increased the likelihood of smoking cessation among their patients. Moadel et al. (2012) found in 
a randomized controlled trial that group therapy was effective in increasing rates of smoking 
cessation, and that self-rated loneliness and self-efficacy were influential factors in cessation. 
Some studies have also investigated the use of technology in smoking cessation counseling 
interventions. Vidrine et al. (2011) found that in a randomized trial of HIV-positive smokers, 
individuals who received a cell phone-delivered smoking cessation intervention were 
significantly more likely to quit smoking at 3 months compared to individuals who received the 
usual care (brief physician advice to quit, written materials, nicotine replacement therapy). 
However, these studies on the effectiveness of smoking cessation method are few in 
number. A review of the literature by Pacek and Cioe (2015b) found that in the previous five 
years, only 10 studies had been conducted to evaluate the effectiveness of smoking cessation 
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interventions among smokers living with HIV. None of these studies looked specifically at 
female smokers living with HIV, even though this group has different smoking cessation rates 
than the general population (Goldberg, 2010). 
One gap in the literature is the prevalence of e-cigarette smoking among people living 
with HIV. Little is known about e-cigarette smoking among the general population to begin with, 
but current estimates are that in 2014, 3.7% of adults currently used e-cigarettes, and 12.6% of 
adults had ever tried one (Schoenborn, 2015). In addition, little is known about e-cigarette’s 
safety or efficacy in quitting smoking. As far as this literature review conducted in March, 2017, 
could tell, there are no studies investigating e-cigarette use specifically among people living with 
HIV. Given the higher prevalence of cigarette smoking in this population, studying this new 
nicotine delivery system is an important gap to fill in the literature. 
This study explored the effectiveness of smoking cessation methods in achieving 6-12-
month sustained smoking cessation among women in the WIHS cohort, April 1 2008 to March 
31 2016. Other factors associated with sustained smoking success were also investigated. This 
study builds on previous research relating to smoking cessation among people living with HIV, 
and adds to it the under-studied population of women living with HIV. The findings from this 
study might allow more tailored and effective recommendations for smoking cessation among 





Participants were enrolled in the Women’s Interagency HIV Study (WIHS), the largest 
ongoing prospective cohort study of HIV among women in the US (Barkan, 1998 & Bacon, 
2005). The WIHS began enrolling in 1994 at six clinical sites: Bronx, NY; Brooklyn, NY; 
Chicago, Il; Los Angeles, CA; San Francisco, CA; and Washington, DC. In 2013, sites in 
Atlanta, GA, Birmingham, AL/Jackson, MS, Chapel Hill, NC, and Miami, FL were added to 
reflect the growing HIV epidemic among women in the southern US. To date, 3,678 HIV-
infected women and 1,304 HIV-uninfected women have been enrolled in the WIHS. 
Women enrolled in the WIHS attend semiannual study visits, at which a trained 
interviewer using standardized methods assesses data on demographics, medical history, 
obstetric/gynecological history, contraceptive use, alcohol, tobacco, and other drug use, and 
sexual behavior. Each visit also includes a physical and gynecological examination. To be 
eligible for enrollment in the 1994-95 cohort, women had to be 13 years or older, give informed 
consent, be tested for HIV, complete the interview in Spanish or English, travel to and from the 
clinic site to complete the baseline visit, and give blood for laboratory testing (Barkan, 1998). To 
recruit a comparable control group of women without HIV, women were recruited from similar 
sources and frequency matched on demographic variables and risk factors (including injection 
drug use since 1978 and total number of sexual partners since 1980) (Barkan, 1998). Highly 
active therapy did not yet exist and many already had an AIDS-defining illness (Bacon, 2005).  
This study incorporates data from 2,511 women who were enrolled prior to 2013 and 
attended at least one study visit on or after visit 28 (April 1, 2008 to September 30, 2008); the 
WIHS began collecting data on smoking cessation method at visit 29 (October 1, 2008 to March 
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31, 2009). Data for these analyses were collected between April 1, 2008 and March 31, 2016. 
Among these 2,511 women, 725 were HIV-uninfected and 1,786 were HIV-infected. 
The main outcome of interest was 6 to 12 months of sustained smoking cessation. A 
participant was considered to have the outcome if she reported that she had quit smoking at one 
visit, and that she was not currently smoking at her next consecutive semiannual visit. The main 
exposure of interest was method of smoking cessation. Starting at visit 29, participants who 
reported that they had quit smoking since their last study visit were asked which methods of 
cessation they had used to help them quit. Participants could report multiple options, so 
categories of methods are not mutually exclusive. Response options included individual 
counseling (support groups, cessation clinics), self-help interventions (like manuals, books, 
tapes), specialist smoking cessation clinics, toll-free telephone help-lines, nicotine replacement 
therapy (including nicotine gum, spray, patch, and inhaler), other pharmacological aids (such as 
medications like Chantix, Wellbutrin, or Buproprion), acupuncture, homeopathy, hypnotherapy, 
exercise, or an otherwise-specified “other” option. Another response option, electronic cigarettes, 
was introduced at visit 35, in October 2011.  
For these analyses, cessation method was collapsed into three categories: behavioral 
(including individual counseling, self-help interventions, telephone help-lines, and specialist 
clinics), pharmacological (including nicotine replacement therapy, other pharmacological aids, 
and electronic cigarettes), and other (including acupuncture, homeopathy, hypnotherapy, 
exercise, and other). Frequency of each method was calculated. A measure of proportional 
success by method was calculated, comparing women who reported trying a method and also 
achieved 6-12-month sustained smoking cessation over all women who reported trying the 
method at their quit visit. 
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Other fixed exposure variables measured at enrollment included age (categorized as 18-
29, 30-39, 40-49, and >50), WIHS enrollment wave (categorized as 1994/1995, 2001/2002, 
2011/2012, and 2013-15), race/ethnicity (categorized as African-American, Hispanic, white, and 
other), and education (categorized as some high school, high school, and some college or 
education beyond college). 
Time-varying covariates included number of cigarettes currently smoked per day, number 
of years the participant smoked cigarettes (categorized as fewer than ten years, ten to twenty 
years, and greater than twenty years), place of residence (dichotomized as living in her own 
place or not), having health insurance (yes or no), average household income per year 
(dichotomized as less than or equal to $12,000 per year or greater than $12,000 per year), 
number of alcoholic drinks per week since the last visit, injection drug use since the last visit 
(yes or no), non-injection recreational drug use since the last visit (yes or no), prescription drug 
use in a way not prescribed (yes or no), depressive symptoms (CES-D, depression threshold 
score of 16), currently pregnant (yes or no), parity, HIV status, participant’s rating of her own 
health (dichotomized as fair/poor or good/excellent), and participant’s rating of her overall 
quality of life (scale of 1 to 10).  
A generalized linear model using Poisson regression and robust standard errors, and 
adjusting for the clustering within WIHS participants, was used to estimate the relative risk of 
sustained (6-12-month) smoking cessation among women who tried to quit smoking. Multiple 
models were fitted to adjust for smoking history variables, other alcohol and drug use, 
demographic variables, and quality of life, self-rated health, and depression variables. Analyses 
were conducted in Stata version 14 (College Station, TX). 
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This study was approved by the Institutional Review Boards at all participating 





 This study included data from 2,511 women who were enrolled in the WIHS prior to 
2013 and attended at least one study visit on or after visit 28 (April 1–Sept 30, 2008). At baseline 
(i.e., the first study visit on or after visit 28), 1,065 women were currently smoking, and 1,446 
women were not currently smoking. At baseline, 342 women had a history of smoking for fewer 
than 10 years, 461 women had a history of smoking for between 10 and 19 years, and 955 
women had a history of smoking for at least 20 years.  Analysis included women who had 
smoked and reported that they had attempted to quit since their last visit (N=685). Of the study 
population, 64% were African American, 19% were Hispanic, 13% were White, and 4% were 
another race/ethnicity. Among methods, the counseling category had the highest prevalence of 
HIV-infected women (77% versus 67% of pharmacological methods and 65% of other methods, 
Table 1).  During the study period, 685 women reported that they had quit smoking since their 
last visit; this includes some women who attempted multiple times. We looked at the first quit 
attempts for each woman, bringing our study population to 595 women (Figure 1). There were 
203 women who had the outcome, 6-12-month sustained smoking cessation, and 392 women 
who had <6-month smoking cessation (i.e., they reported quitting but did not have sustained 
smoking cessation at their next study visit) (Table 2). 16 of the 203 women who achieved 6-12-
month sustained smoking cessation did not report that any of the smoking cessation methods 
were helpful to her in quitting. 
 Of the three categories of smoking cessation method, counseling, pharmacological, and 
other, the other category was the most common among women with 6-12-month smoking 
cessation (Table 2). This category included methods such as acupuncture (n=2), homeopathy 
(n=3), hypnosis (n=2), and exercise (n=6), which were not frequently used among sustained 6-
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12-month smoking cessations, but also included a self-reported open field response (Table 2). An 
analysis of these responses revealed that the most common method among women with 6-12-
month smoking cessation in the other category was “cold turkey” or “just stopped” (n=29), and 
the second-most common method was “on her own” or “by herself” (n=28). Other open field 
responses included incarceration, health problems (most commonly, asthma), and family 
concerns (pregnancy or citing family members such as granddaughters). 
The most common method mentioned among all women who made a quit attempt was 
nicotine replacement therapy (n=193), followed by “cold turkey” (n=98) and “on her own” 
(n=80). Among women who achieved 6-12-month sustained smoking cessation, self-help 
interventions were the most commonly used of the counseling interventions (n=28). Of the 
pharmacological interventions, nicotine replacement therapy was the most common method 
(n=52). Also of interest were 12 participants who achieved 6-12-month sustained smoking 
cessation using e-cigarettes, compared to the 34 participants who reported using e-cigarettes but 
did not achieve 6-12-month sustained smoking cessation. 
The methods with the highest proportion of women who achieved 6-12-month sustained 
smoking cessation among all women who tried the method were the self-help interventions 
(36.4% of those who reported using this method at their quit visit went on to have 6-12-month 
sustained smoking success), quitting “on her own” (35.0%), other pharmacological aids (32.0%), 
and quitting “cold turkey” (29.6%) (Table 2). Among women who reported using homeopathy, 
75% achieved 6-12-month sustained smoking cessation, although only 4 women reported using 
it. 
 In univariate analysis, method of smoking cessation (counseling, pharmacological, or 
other) was significantly associated with sustained 6-12-month smoking cessation, whereby 
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women who used counseling methods were more likely to have quit for 6-12 months (IRR 
compared to pharmacological method = 0.55, 95% CI: 0.38, 0.80 and IRR compared to other 
methods = 0.61, 95% CI: 0.43, 0.86, Table 3).  
 Model 2 was adjusted for two variables relating to smoking history: number of cigarettes 
smoked per day and number of years smoked, both measured at the visit immediately prior to 
visit at which the woman reported quitting. In this model, an increase of one cigarette smoked 
per day was associated with a 15% lower rate of achieving smoking cessation success 
(IRR=0.85, 95% CI: 0.80, 0.90, Table 4). Smoking for 10 to 20 years, as compared to less than 
10 years, was associated with a 29% lower rate of achieving smoking cessation (IRR=0.71, 95% 
CI: 0.50, 1.01) and smoking for greater than 20 years, as compared to less than 10 years, was 
associated with a 41% lower rate of achieving smoking cessation (IRR=0.59, 95% CI: 0.44, 
0.80). Controlling for smoking history variables, pharmacological methods were no longer 
significantly associated with a reduced risk of achieving smoking cessation as compared to 
counseling methods (IRR=0.71, 95% CI: 0.50, 1.02), but other methods were still significant, 
and had a 37% lower incidence of cessation success, compared to counseling methods 
(IRR=0.63, 95% CI: 0.45, 0.88). 
 Model 3 included additional substance use variables: number of alcoholic drinks per 
week, injection drug use since the last visit, non-injection recreational drug use since the last 
visit, and recreational prescription drug use, all measured at the visit before the quit attempt 
(Table 5). None had statistically significant reductions in the rate of cessation success (p>0.05). 
After adjusting for substance use, use of other method as compared to counseling still had a 
significant reduction in the rate of cessation success (IRR=0.62, 95% CI:0.44, 0.86), and number 
of cigarettes (IRR=0.85, 95% CI: 0.80, 0.90) and greater than twenty years of smoking history, 
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as compared to less than ten years (IRR=0.59, 95% CI: 0.44, 0.80), were both still significantly 
associated with reduction in the rate of cessation success. 
 Model 4 also included demographic characteristics: education (categorized as less than 
high school, high school, and more than high school), race (categorized as African American, 
Hispanic, white, and other), WIHS enrollment wave, age, health insurance, residence, household 
income (dichotomized as less than or equal to $12,000 per year and greater than $12,000 per 
year), being currently pregnant, parity, and HIV status. These covariates were all measured at the 
visit before the quit attempt (Table 6). Not having her own place of residence was significantly 
associated with having a 47% reduction in the rate of smoking cessation success (IRR=0.53, 
95% CI: 0.33, 0.85). Being Hispanic, as compared to being African American, had a 40% 
increased incidence of smoking cessation success (IRR=1.40, 95% CI: 1.05, 1.87). Smoking 
history variables remained significant: an increase of one cigarette in the number of cigarettes 
smoked per day was associated with a 14% lower incidence of smoking cessation success 
(IRR=0.86, 95% CI: 0.81, 0.91), and smoking for twenty years, as compared to less than ten 
years, had a 51% lower incidence of smoking cessation success (IRR=0.49, 0.33, 0.71). After 
adjusting for demographic variables, neither smoking cessation method, as compared to 
counseling, was significant (pharmacological IRR=0.83, 95% CI: 0.56, 1.23; other IRR=0.74, 
95% CI: 0.51, 1.08). Other covariates were no longer significant. 
Model 5 included all previous covariates, as well as depressive symptoms (CES-D score 
of greater than 16), self-rated health perception (dichotomized as poor/fair or good/excellent), 
and self-rated overall quality of life (scale from 1 to 10). Having a good or excellent self-rated 
health perception, as compared to having a poor or fair health perception, was associated with a 
59% increase in the rate of sustained smoking cessation success (IRR=1.59, 95% CI: 0.98, 2.58, 
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Table 7). With all covariates included, a higher number of cigarettes smoked per day was still 
associated with a reduction in the incidence of smoking cessation success (IRR=0.89, 95% CI: 
0.83, 0.95), as was having smoked for greater than twenty years as compared to fewer than ten 
(IRR=0.46, 95% CI: 0.25, 0.85) and having smoked for ten to twenty years as compared to less 
than ten years (IRR=0.59, 95% CI: 0.34, 1.02). Not having a place of one’s own to reside in, as 
compared to women who did have their own place of residence, was also still associated with a 





This study found that, after adjusting for covariates, method of smoking cessation was 
not significantly associated with a reduction in the incidence of achieving 6-12-month sustained 
smoking cessation, but other factors, like number of cigarettes smoked per day before quitting, 
number of years having been a smoker before quitting, having her own residence, and good to 
excellent self-rated health were all significantly associated with 6-12-month sustained smoking 
cessation among women in the WIHS. The methods with the highest proportion of women who 
achieved 6-12-month sustained smoking cessation were self-help interventions, quitting “on her 
own”, quitting “cold turkey”, and nicotine replacement therapy. This study also found that 
nicotine replacement therapy was the most commonly reported method of smoking cessation.  
The findings here are similar to the previous literature, which found that individual and 
counseling interventions have been effective in achieving smoking cessation among HIV-
infected populations (Huber, 2012). Other covariates associated with 6-12-month sustained 
smoking cessation, such as self-rated health, number of cigarettes, and smoking history, were 
also similar to previous research on smoking cessation in the WIHS (Hessol, 2014).  
One strength of this study is that the Women’s Interagency HIV Study’s longitudinal 
design allows us to establish temporality. We know what women’s smoking habits and other 
covariates were at the visit before they reported having quit smoking. The representativeness of 
the cohort, meant to represent women with HIV and at risk for HIV in the United States, also 
allows us to generalize our findings to the portion of this population in the United States that 
smokes and attempts to quit. Finally, a strength of this study is that it fills a gap in the literature 
by exploring the effectiveness of cessation methods among women smokers living with HIV. 
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The main limitation of this study is that women were only asked about cessation method 
as a follow-up question, if they first responded that they had quit smoking since their last visit. In 
other words, method of cessation was not assessed for women who may have tried to quit, but 
failed, between visits. Some more resource-intensive methods, such as specialist smoking 
cessation clinics, were not commonly reported (n=9), but it is not clear how accessible these 
methods were to the women in the study population. It is also unknown whether the women had 
tried to quit smoking before, and what methods she had used previously. Previous research 
estimates that smokers attempt to quit 30 or more times before quitting successfully (Chaiton, 
2016). An understanding of a woman’s quit attempt history would have been helpful in 
predicting her sustained smoking cessation success. Finally, another limitation is that the option 
for choosing e-cigarettes as a helpful cessation method was not introduced until October 2011. 
The study could therefore have missed women who used this method prior to its introduction on 
the questionnaire. These limitations should be taken into account when interpreting our 
conclusions. 
This study has implications for interventions designed to assist HIV-infected and at-risk 
women in achieving smoking cessation. It provides information on the methods with the highest 
proportion of women who achieved 6-12-month smoking cessation and the most commonly 
reported methods in this population, which could be used to more effectively target 
interventions. Future interventions should recognize other factors that influence successful 
smoking cessation, like self-rated health and residence, and incorporate these concerns into their 
counseling. Some current research has taken this into account. A study by Balfour, et al (2017) 
found success in a randomized controlled trial by addressing depressive symptoms among HIV-
infected smokers in combination with standard nicotine replacement therapy and counseling. 
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Future interventions should also expand access to methods that have been found in previous 
studies to be effective, such as group workshops, but were not commonly used in this population. 
In conclusion, this analysis of smoking cessation methods among women smokers who 
tried to quit in the Women’s Interagency HIV Study found that, in the unadjusted model, the 
most effective methods of achieving 6-12-month sustained smoking cessation were self-help 
interventions, quitting “on her own,” other pharmacological aids, and quitting “cold turkey.” 
Accounting for other factors, characteristics associated with the likelihood of achieving 6-12-
month sustained cessation include number of cigarettes smoked per day at the visit before the 
quit attempt, smoking history, place of residence, and self-rated health. This study fills a gap in 
the literature on smoking cessation strategies for women smokers living with HIV. These 
findings could help clinicians and researchers more effectively tailor interventions for smoking 
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Table 1: Baseline characteristics of current smokers by smoking cessation method category in 
the WIHS (April 1, 2008 - March 31, 2016), N=595 
 Counseling Pharmacological Other 
 N (%) N (%) N (%) 
Age group    
18-29 3 (2) 5 (2) 14 (4) 
30-39 25 (17) 39 (15) 77 (23) 
40-49 61 (40) 101 (39) 106 (32) 
>50 68 (45) 125 (49) 154 (46) 
Enrollment 
wave 
   
1994-1995 87 (58) 137 (53) 168 (50) 
2001-2002 37 (25) 73 (28) 120 (36) 
2011-2012 27 (18) 47 (18) 45 (14) 
Race/ethnicity    
African- 
American 
97 (64) 164 (64) 219 (66) 
Hispanic 21 (14) 39 (15) 68 (20) 
White 27 (18) 48 (19) 36 (11) 
Other 6 (4) 6 (2) 10 (3) 
Number of 
years smoked 
   
0-10 11 (7) 9 (4) 48 (14) 
10-19 36 (24) 51 (20) 68 (20) 
>20 106 (70) 201 (78) 224 (67) 
HIV Status    
Uninfected 35 (23) 86 (33) 116 (35) 
Infected 116 (77) 171 (67) 217 (65) 
Counseling methods: smoking cessation advice, individual 
counseling, self-help interventions, group sessions/workshops, 
telephone helplines, and specialist smoking cessation clinics. 
Pharmacological methods: nicotine replacement therapy, other 
pharmacologic aids, electronic cigarettes. Other methods: 
acupuncture, homeopathy, hypnotherapy, exercise, other. 












Table 2: Smoking cessation by cessation method* among women who reported having quit in the 
WIHS (April 1 2008 to March 31 2016) 









women who tried 
the method  
 N (%)  N (%)  
Counseling    
Advice 9 (4) 34 (9) 0.21 
Individual counseling 5 (2) 16 (4) 0.24 
Self-help interventions 28 (14) 49 (13) 0.36 
Group sessions/workshops 2 (1) 14 (4) 0.13 
Telephone help-lines 7 (3) 20 (5) 0.26 
Specialist smoking 
cessation clinics 
1 (0.5) 8 (2) 0.11 
Total 40 (20) 82 (21) 0.33 
Pharmacological    
Nicotine replacement 
therapy 
52 (26) 141 (36) 0.27 
Other pharmacological aid 16 (8) 34 (9) 0.32 
E-cigarettes 12 (6) 34 (9) 0.26 
Total 67 (33) 173 (44) 0.28 
Other    
Acupuncture 2 (1) 10 (3) 0.17 
Homeopathy 3 (1) 1 (0.3) 0.75 
Hypnosis 2 (1) 8 (2) 0.20 
Exercise 6 (3) 20 (5) 0.23 
“Cold turkey” 29 (14) 69 (18) 0.30 
“On her own” 28 (14) 52 (13) 0.35 
Other 13 (6) 64 (16) 0.17 
Total 80 (39) 189 (48) 0.30 






Table 3: Model 1, univariate incidence rate ratio of 6-12-month sustained smoking cessation 
among women who reported having quit in the WIHS (April 1, 2008 to March 31, 2016) 
 IRR (95% CI) Robust Standard Error 
Cessation method   
Counseling 1.00 (reference)  
Pharmacological 0.55 (0.38, 0.80) 0.10 
Other 0.61 (0.43, 0.86) 0.11 






Table 4: Model 2, incidence rate ratio of 6-12-month sustained smoking cessation among women 
who reported having quit in the WIHS (April 1 2008 to March 31 2016), adjusted for smoking 
history characteristics 
 IRR (95% CI) Robust Standard Error 
Cessation method   
Counseling 1.00 (reference)  
Pharmacological 0.71 (0.50, 1.02) 0.13 
Other 0.63 (0.45, 0.88) 0.11 
Number of cigarettes smoked daily (+1)  0.85 (0.80, 0.90) 0.02 
Smoking history   
<10 years 1.00 (reference)  
10-20 years 0.71 (0.50, 1.01) 0.13 
>20 years 0.59 (0.44, 0.80) 0.09 
Constant 0.73 (0.51, 1.04) 0.13 
*Smoking history characteristics adjusted for were number of cigarettes smoked per day and 







Table 5: Model 3, incidence rate ratio of 6-12-month sustained smoking cessation among women 
who reported having quit in the WIHS (April 1 2008 to March 31 2016), adjusted for smoking 
history and substance use characteristics  
 IRR (95% CI) Robust Standard Error 
Cessation method   
Counseling 1.00 (reference)  
Pharmacological 0.70 (0.50, 1.00) 0.13 
Other 0.62 (0.44, 0.86) 0.10 
Number of cigarettes smoked daily (+1) 0.85 (0.80, 0.90) 0.03 
Smoking history   
<10 years 1.00 (reference)  
10-20 years 0.72 (0.50, 1.04) 0.13 
>20 years 0.59 (0.44, 0.80) 0.09 
Number of drinks per week 1.00 (0.99, 1.01) 0.00 
Injected drugs since last visit   
No 1.00 (reference)  
Yes 1.40 (0.39, 4.92) 0.90 
Non-injected recreational since last visit    
No 1.00 (reference)  
Yes 0.88 (0.67, 1.16) 0.12 
Use of rx drugs in way not prescribed   
No 1.00 (reference)  
Yes 1.02 (0.26, 4.01) 0.71 





Table 6: Model 4, incidence rate ratio of 6-12-month sustained smoking cessation among women 
who reported having quit in the WIHS (April 1 2008 to March 31 2016), adjusted for smoking 
history, substance use, and demographic characteristics 
  IRR Robust Std Err (95% CI) andard 
Error 
Cessation method   
Counseling 1.00 (reference)  
Pharmacological 0.83 (0.56, 1.23) 0.17 
Other 0.74 (0.51, 1.08) 0.14 
Number of cigarettes smoked 0.85 (0.81, 0.91) 0.03 
Smoking history   
<10 years 1.00 (reference)  
10-20 years 0.69 (0.47, 1.01) 0.13 
>20 years 0.49 (0.33, 0.71) 0.10 
Number of drinks per week 1.00 (0.99, 1.01) 0.00 
Number of drinks per week 1.00 0 Injected drugs since last visit   
No 1.00 (reference)  
Yes 1.65 (0.45, 6.05) 1.10 
Non-injected recreational since 
last visit  
  
No 1.00 (reference)  
Yes 0.96 (0.71, 1.28) 0.14 
Use of rx drugs in way not 
prescribed 
  
No 1.00 (reference)  
Yes 1.28 (0.39, 4.23) 0.78 
Education   
Less than high school 1.00 (reference)  
High school 1.13 (0.81, 1.58) 0.19 
More than high school 1.19 (0.87, 1.62) 0.19 
Race/ethnicity   
African American 1.00 (reference)  
Hispanic 1.40 (1.05, 1.87) 0.21 
White 1.25 (0.87, 1.77) 0.22 
Other 0.65 (0.19, 2.24) 0.41 
WIHS wave   
1994/95 recruit 1.00 (reference)  
2001/02 recruit 0.84 (0.61, 1.17) 0.14 
2011/12 recruit 0.72 (0.47, 1.10) 0.16 
Age 1.01 (0.99, 1.03) 0.01 
Has health insurance   
No 1.00 (reference)  
Yes 1.11 (0.70, 1.77) 0.26 














































Lives in her own place   
No 1.00 (reference)  
Yes 0.53 (0.33, 0.85) 0.13 
Income greater than 
$12,000/year 
  
No 1.00 (reference)  
Yes 0.96 (0.75, 1.23) 0.12 
Currently pregnant   
No 1.00 (reference)  
Yes 1.08 (0.58, 2.02) 0.34 
Parity 0.99 (0.93, 1.05) 0.03 
HIV-infected   
No 1.00 (reference)  
Yes 0.91 (0.69, 1.21) 0.13 
Constant 1.16 (0.31, 4.34) 0.78 
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Table 7: Incidence rate ratio of 6-12-month sustained smoking cessation among women who 
reported having quit in the WIHS (April 1 2008 to March 31 2016), adjusted for smoking 
history, substance use, demographic characteristics, and depression, self-rated health, and quality 
of life 
 IRR Robust Std Err (95% CI) andard 
Error 
Cessation method   
Counseling 1.00 (reference)  
Pharmacological 1.10 (0.60, 2.02) 0.34 
Other 1.09 (0.59, 2.01) 0.34 
Number of cigarettes smoked 0.89 (0.83, 0.95) 0.03 
Smoking history   
<10 years 1.00 (reference)  
10-20 years 0.59 (0.34, 1.02) 0.16 
>20 years 0.46 (0.25, 0.85) 0.14 
Number of drinks per week 1.00 (0.99, 1.02) 0.01 
Number of drinks per week 1.00 0 Injected drugs since last visit   
No 1.00 (reference)  
Yes 0.00 (0.00, 0.00) 0.00 
Non-injected recreational since last visit    
No 1.00 (reference)  
Yes 0.95 (0.62, 1.44) 0.20 
Use of rx drugs in way not prescribed   
No 1.00 (reference)  
Yes 0.70 (0.12, 4.01) 0.62 
Education   
Less than high school 1.00 (reference)  
High school 1.33 (0.85, 2.08) 0.30 
More than high school 1.21 (0.81, 1.82) 0.25 
Race/ethnicity   
African American 1.00 (reference)  
Hispanic 1.11 (0.73, 1.69) 0.24 
White 1.25 (0.82, 1.91) 0.27 
Other 0.00 (0.00, 0.00) 0.00 
WIHS wave   
1994/94 recruit 1.00 (reference)  
2001/02 recruit 0.63 (0.40, 1.00) 0.15 
2011/12 recruit 0.58 (0.31, 1.10) 0.19 
Age 1.00 (0.91, 1.03) 0.01 
Has health insurance   
No 1.00 (reference)  
Yes 0.80 (0.43, 1.50) 0.26 










No 1.00 (reference)  
Yes 0.50 (0.25, 0.99) 0.18 
Income greater than $12,000/year   
No 1.00 (reference)  
Yes 0.81 (0.56, 1.17) 0.15 
Currently pregnant   
No 1.00 (reference)  
Yes 1.10 (0.56, 2.16) 0.38 
Parity 0.98 (0.90, 1.06) 0.04 
HIV-infected   
No 1.00 (reference)  
Yes 1.03 (0.68, 1.56) 0.22 
CES-D score >16 (depressed)   
No 1.00 (reference)  
Yes 0.72 (0.45, 1.17) 0.18 
Good to excellent self-rated health   
No 1.00 (reference)  
Yes 1.59 (0.98, 2.58) 0.39 
Quality of life scale 0.97 (0.88, 1.07) 0.05 
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